PPK Group Limited (ASX: PPK) has entered into a new Joint Venture Research Agreement (JVRA) to further develop ground-breaking BNNT technology.
The JVRA with Deakin University and BNNT Technology Limited is looking to advance research into a range of potential commercial opportunities for Boron Nitride Nanotubes (BNNT).
The initial list of new application projects for BNNT targeted by the JVRA (include the development of:
This new JV follows a November 2018 agreement with Deakin University to manufacture BNNT on a commercial basis through BNNT Technology Limited, the joint venture company owned 50% by PPK. BNNTTL holds an exclusive 20-year license in respect of the BNNT technology developed by Deakin University.
A test production plant was constructed at Deakin University at Geelong, Victoria and in early October 2019 Deakin confirmed that each of the process elements of the production plant were completed and the plant was operational.
An ongoing development programme is now focused on establishing the range of production process settings required for BNNT purity, size and type to allow the initiation of higher volume production.
The Joint Venture shareholding structure is comprised with PPK owning 65%, Deakin University holding 25% and BNNTTL holding the 10% balance.
PPK Executive Chairman Robin Levison said the new agreement further strengthens the relationship between Deakin University and PPK.
We are delighted to be again working alongside Deakin University to assist in the enablement and commercialisation initially of these six market leading applications.
“The Board and management of PPK have been greatly encouraged by the investor support shown since the initial BNNT announcement in November 2018 and are confident that these new technology commercialisation opportunities will not only be beneficial to PPK in the medium term but also create a portfolio development effect that both increases revenue and profitability opportunities for PPK whilst reducing overall commercialisation risk.”
PPK has also agreed to a placement to raise $8.5M with funds to be utilised in the advancement of the JV research and to further develop BNNT identified opportunities.